We are live on ! Find out more
RVM

RiverVest Venture Management Portfolio holdings

AUM $6.84M
1-Year Est. Return 7.71%
This Fund
S&P 500
This Quarter Est. Return
-6.43%
1 Year Est. Return
-7.71%
3 Year Est. Return
-16.51%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$40.4M
AUM Growth
-$49.7M
Cap. Flow
-$41.6M
Cap. Flow %
-102.81%
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
2
Reduced
–
Closed
1

Top Buys

Rank Stock Value
1
ALLK
Allakos
ALLK
+$370K
2
VAPO
Vapotherm, Inc. Common Stock
VAPO
+$1.02K

Top Sells

Rank Stock Value
1
MIRM icon
Mirum Pharmaceuticals
MIRM
+$41.9M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OKUR
1
OnKure Therapeutics
OKUR
$155M
$19.3M 47.73%
253,422
– –
ALLK
2
DELISTED
Allakos
ALLK
$11.3M 28%
4,987,522
+99,590
+2% +$370K
SPRB
3
Spruce Biosciences
SPRB
$182M
$6.64M 16.41%
39,150
– –
XLO icon
4
Xilio Therapeutics
XLO
$59.3M
$3.04M 7.52%
102,960
– –
VAPO
5
DELISTED
Vapotherm, Inc. Common Stock
VAPO
$133K 0.33%
52,552
+326
+0.6% +$1.02K
MIRM icon
6
Mirum Pharmaceuticals
MIRM
$6.08B
– –
-1,621,118
Closed -$41.9M

Similar funds

JDR
Jay D. Rosenbaum $6.69M AUM 4.68% 1-Year Est. Return
KIM
Kaizen Investment Management Singapore $6.23M AUM
ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
HVM
Harvest Volatility Management Norwalk, Connecticut $4.39M AUM 13.08% 1-Year Est. Return
BGC
Birch Grove Capital New York $9.51M AUM 0.22% 1-Year Est. Return
QC
QCM Cayman Houston, Texas $3.63M AUM 61.13% 1-Year Est. Return
CU
Cornell University New York $3.44M AUM 9.69% 1-Year Est. Return
PWA
Pillar Wealth Advisors West Chester, Pennsylvania $3.35M AUM 22.3% 1-Year Est. Return

RiverVest Venture Management's Q3 2023 Portfolio in Review

As of Q3 2023, RiverVest Venture Management held 6 positions worth $40.4M, down 55% from $90.2M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

RiverVest Venture Management withdrew a net $41.6M in Q3 2023, closing 1 position. Its most notable exit was Mirum Pharmaceuticals, an estimated $41.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, RiverVest Venture Management added an estimated $370K to Allakos.

  • RiverVest Venture Management added most to Allakos in Q3 2023, an estimated $370K increase.
  • RiverVest Venture Management fully exited Mirum Pharmaceuticals in Q3 2023, selling an estimated $41.9M.
  • RiverVest Venture Management's ten largest holdings make up 100% of its $40.4M portfolio in Q3 2023.
  • RiverVest Venture Management opened 0 new positions and closed 1 in Q3 2023.
  • RiverVest Venture Management's portfolio value fell 55% quarter-over-quarter to $40.4M.

Based on RiverVest Venture Management's 13F filing for Q3 2023, filed 30 Oct 2023.